A novel agent, p-toluenesulfonamide, in the management of malignant pleural effusions.

Saved in:
Bibliographic Details
Title: A novel agent, p-toluenesulfonamide, in the management of malignant pleural effusions.
Authors: Luo YH; Department of Chest Medicine, Taipei Veterans General Hospital and School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei 112, Taiwan. Electronic address: yhluo@vghtpe.gov.tw., Yang CC; Gongwin Biopharm Co., Ltd., Taipei 104, Taiwan., Wu SC; Gongwin Biopharm Co., Ltd., Taipei 104, Taiwan., Su HW; Gongwin Biopharm Co., Ltd., Taipei 104, Taiwan., Hsing YC; Gongwin Biopharm Co., Ltd., Taipei 104, Taiwan., Lin SY; Gongwin Biopharm Co., Ltd., Taipei 104, Taiwan., Lo YC; Gongwin Biopharm Co., Ltd., Taipei 104, Taiwan., Lin MY; Gongwin Biopharm Co., Ltd., Taipei 104, Taiwan., Li SY; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China., He J; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China., Kuo SW; Department of Surgery, College of Medicine, National Taiwan University Hospital and National Taiwan University, Taipei 100, Taiwan. Electronic address: shuenn@ntuh.gov.tw.
Source: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2025 Dec; Vol. 210, pp. 108814. Date of Electronic Publication: 2025 Nov 03.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1872-8332
DOI:10.1016/j.lungcan.2025.108814